Editorial: current challenges for targeting brown fat thermogenesis to combat obesity
Autor/a
Yoneshiro, Takeshi
Rodríguez-Rodríguez, Rosalía
Johannes Betz, Matthias
Rensen, Patrick C. N.
Data de publicació
2020-10-27ISSN
1664-2392
Resum
Just over a decade has passed since metabolically active brown adipose tissue (BAT) was unequivocally identified in healthy adult humans. Since then, researchers have provided evidence of expression of the thermogenic molecule uncoupling protein 1 (UCP1) in human BAT, as well as its energy dissipating capacity. Additionally, clinical cross-sectional analysis suggested that a decline in BAT activity with aging, as judged from [18F]FDG-PET/CT, coincides with the development of obesity and insulin resistance. These major observations provided a rationale to investigate BAT as a potential target for preventing obesity. Indeed, several studies have demonstrated that cold exposure and adrenomimetic agents strongly activate BAT thermogenesis, and thus energy expenditure in humans. However, the extent to which stimulating BAT thermogenesis decreases adiposity in humans remains unclear. Moreover, therapeutic strategies aimed at general stimulation of the sympathetic nervous system (SNS) and adrenergic receptors involved may not be applicable for obese and diabetic patients, because of potential negative side-effects on cardiovascular function. While implementation in humans remains challenging, recent studies in mice have yielded insights in molecular mechanisms underlying thermogenic regulation of brown and brown-like (brite/beige) adipocytes, highlighting their ability to reduce insulin resistance and atherosclerosis (1). These include identification of UCP1-independent thermogenesis as well as peripheral organ-derived endocrine factors and metabolites capable of triggering adipocyte thermogenesis. Activating these non-canonical mechanisms through genetic manipulation or pharmacological agents suppresses obesity and its associated complications in mice. The major challenge remains translating preclinical scientific advances to humans. To bridge basic research with clinical investigation, this Research Topic reviews the current advances in human BAT pathophysiology, novel molecular mechanisms regulating adipose thermogenesis, and remaining challenges in this field.
Tipus de document
Article
Versió del document
Versió publicada
Llengua
English
Matèries (CDU)
61 - Medicina
Paraules clau
Teixit adipós
Metabolisme
Obesitat
Diabetis
Tejido adiposo
Metabolisme
Obesidad
Diabetes
Adipose tissue
Metabolism
Obesity
Diabetes
Pàgines
4
Publicat per
Frontiers Media
Col·lecció
11;
Publicat a
Frontiers in Endocrinology
Citació
Yoneshiro, Takeshi; Rodríguez-Rodríguez, Rosalía; Johannes Betz, Matthias [et al.]. Editorial: current challenges for targeting brown fat thermogenesis to combat obesity. Frontiers in Endocrinology, 2020, 11, p. 4. Disponible en:<https://www.frontiersin.org/articles/10.3389/fendo.2020.600341/full>. Fecha de acceso: 3 feb. 2021. DOI: 10.3389/fendo.2020.600341
Número de l'acord de la subvenció
info:eu-repo/grantAgreement/ES/2PE/SAF2017-82813-C3-3R
Aquest element apareix en la col·lecció o col·leccions següent(s)
- Ciències de la Salut [740]
Drets
© 2020 Yoneshiro, Rodríguez-Rodríguez, Betz and Rensen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com https://creativecommons.org/licenses/by/4.0/